Potential role of P-glycoprotein in affecting hepatic metabolism of drugs

Pharmaceutical Research

Volumn 17, Issue 8, 2000, Pages 903-905

  Chiou, W L ^a   Chang, S M ^a   Wu, T C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Drug interaction; First pass metabolism; Hepatic metabolism; P glycoprotein; Pharmacokinetics

Indexed keywords

CYCLOSPORIN; ERYTHROMYCIN; GLYCOPROTEIN P; INDINAVIR; NELFINAVIR; PACLITAXEL; QUINIDINE; RIFAMPICIN; SAQUINAVIR; TACROLIMUS; VINBLASTINE;

BILE SECRETION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG METABOLISM; FIRST PASS EFFECT; HUMAN; METABOLIC CLEARANCE RATE; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL;

ANIMALS; HUMANS; LIVER; P-GLYCOPROTEIN; PHARMACEUTICAL PREPARATIONS;

EID: 0033795486     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007570517183     Document Type: Note

References (17)

1. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
2. Drug disposition as determined by the interplay between drug-transporting and drug-metabolizing systems
3. P-glycoprotein-dependent disposition kinetics of tacrolimus: Studies in mdr1a knockout mice
4. Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug delivery
5. P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans
6. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes
7. Apparent lack of effect of P-glycoprotein on the gastrointestinal absorption of a substrate, tacrolimus, in normal mice
8. Altered pharmacokinetics of vinblastine in mdr1a P-glycoprotein-deficient mice
9. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
10. Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a) pyrene
11. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
12. Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine
13. Metabolism of propionyl erythromycin lauryl sulfate. I. Fate of the propionyl erythromycin moiety in the rat
14. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-I protease inhibitors
15. Commentary: A physiological approach to hepatic drug clearance
16. The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice
17. The barrier function of CYP3A4 and P-glycoprotein in the small bowel